|
MICALL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.497700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75618999999072E-05 |
| Normal-vs-Stage2 |
8.035300E-03 |
| Normal-vs-Stage3 |
4.528800E-01 |
| Normal-vs-Stage4 |
7.341700E-02 |
| Stage1-vs-Stage2 |
6.904600E-01 |
| Stage1-vs-Stage3 |
3.746200E-02 |
| Stage1-vs-Stage4 |
6.522400E-01 |
| Stage2-vs-Stage3 |
6.844200E-02 |
| Stage2-vs-Stage4 |
4.769800E-01 |
| Stage3-vs-Stage4 |
1.342040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.356010E-04 |
| Normal-vs-AfricanAmerican |
1.958130E-03 |
| Normal-vs-Asian |
2.465900E-02 |
| Caucasian-vs-AfricanAmerican |
9.423800E-01 |
| Caucasian-vs-Asian |
8.159200E-01 |
| AfricanAmerican-vs-Asian |
8.043200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32809999999306E-05 |
| Normal-vs-Female |
7.139600E-01 |
| Male-vs-Female |
1.353710E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.543700E-02 |
| Normal-vs-Extreme_Weight |
3.74600000000447E-05 |
| Normal-vs-Obese |
2.656800E-01 |
| Normal-vs-Extreme_Obese |
2.447800E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.128020E-01 |
| Normal_Weight-vs-Obese |
5.419600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.658000E-02 |
| Extreme_Weight-vs-Obese |
7.006300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.457600E-01 |
| Obese-vs-Extreme_Obese |
3.868200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.451800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.196200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.87110000000091E-05 |
| Normal-vs-Age(81-100Yrs) |
7.68710000098594E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.269760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.523800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.998500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.252200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.1781000000074E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.178500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.43570002739824E-09 |
| Normal-VS-Type2 PRCC |
1.455620E-03 |
| Normal-VS-KIRP CIMP |
2.907600E-02 |
| Normal-VS-Unclassified PRCC |
2.198800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.908400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.575900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.118300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.054080E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.496790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.950020E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.405200E-04 |
| Normal-vs-N1 |
4.482200E-01 |
| Normal-vs-N2 |
7.077000E-01 |
| N0-vs-N1 |
5.313700E-02 |
| N0-vs-N2 |
8.339600E-02 |
| N1-vs-N2 |
9.956600E-01 |
|
|
